Korean J Helicobacter Up Gastrointest Res.  2016 Dec;16(4):185-188. 10.7704/kjhugr.2016.16.4.185.

Guidance for Endoscopic Procedures in Patients Taking Novel Oral Anticoagulants

• Kim KO

• KMID: 2383557
• DOI: http://doi.org/10.7704/kjhugr.2016.16.4.185

Abstract

Anticoagulant agents are used to reduce the risk of thromboembolic complications in patients with atrial fibrillation or deep vein thrombosis. Several new generation of oral anticoagulants have been approved. These novel oral anticoagulants (NOACs) include direct thrombin inhibitors, dabigatra etexilate, and the direct factor Xa inhibitors, rivaroxaban, apixaban and edoxaban. This review evaluates NOACs-related gastrointestinal bleeding and summarizes the ideal management strategies based on the guideline suggested by American Society for Gastrointestinal Endoscopy.

Keyword

Anticoagulants; Endoscopy; Gastrointestinal hemorrhage; Thromboembolism

MeSH Terms

Anticoagulants*
Antithrombins
Atrial Fibrillation
Endoscopy
Endoscopy, Gastrointestinal
Factor Xa Inhibitors
Gastrointestinal Hemorrhage
Hemorrhage
Humans
Rivaroxaban
Thromboembolism
Venous Thrombosis
Anticoagulants
Antithrombins
Factor Xa Inhibitors
Rivaroxaban